Clinical Trial Update: Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the efficacy and safety of adding oral dehydroepiandrosterone (DHEA) to oral contraceptives in women with reduced libido. The study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Dehydroepiandrosterone (dehydroepiandrosterone)

Snippet

Sponsor: Bayer | Conditions: Libido | Phase 2 | Status: COMPLETED